Total cholesterol, mg/dl
| | | |
Baseline
|
212.8 (7.7)
|
200.1 (8.4)
|
208.7 (9.1)
|
Change from baseline at day 29
|
−0.8 (3.6)
|
3.2 (3.7)
|
1.1 (3.7)
|
Difference vs placebo (95% CI)
| |
4.0 (−6.6, 14.6)
|
1.9 (−8.6, 12.3)
|
p-value
| |
0.455
|
0.722
|
HDL-cholesterol, mg/dl
| | | |
Baseline
|
46.8 (2.2)
|
47.6 (2.8)
|
46.8 (2.8)
|
Change from baseline at day 29
|
0.1 (1.2)
|
4.7 (1.3)
|
7.4 (1.3)
|
Difference vs placebo (95% CI)
| |
4.5 (1.0, 8.1)
|
7.2 (3.7, 10.8)
|
p-value
| |
0.014
|
<0.001
|
LDL-cholesterol, mg/dl
| | | |
Baseline
|
128.7 (6.3)
|
124.9 (8.4)
|
130.5 (8.5)
|
Change from baseline at day 29
|
−1.3 (3.2)
|
3.4 (3.3)
|
4.3 (3.3)
|
Difference vs placebo (95% CI)
| |
4.7 (−4.6, 14.0)
|
5.7 (−3.5, 14.8)
|
p-value
| |
0.314
|
0.221
|
Triglycerides, mg/dl*
| | | |
Baseline
|
159.6 (51.0)
|
131.5 (34.9)
|
142.2 (48.0)
|
Relative change from baseline at day 29
|
1.0 (0.9, 1.1)
|
0.8 (0.7, 0.9)
|
0.7 (0.6, 0.8)
|
Difference vs placebo (95% CI)
| |
0.8 (0.7, 1.0)
|
0.7 (0.6, 0.8)
|
p-value
| |
0.037
|
<0.001
|
Free fatty acids, mg/dl
| | | |
Baseline
|
10.8 (0.8)
|
9.6 (0.7)
|
9.3 (0.6)
|
Change from baseline at day 29
|
3.1 (0.8)
|
4.8 (0.8)
|
7.4 (0.8)
|
Difference vs placebo (95% CI)
| |
1.7 (−0.6, 4.1)
|
4.3 (2.0, 6.7)
|
p-value
| |
0.149
|
<0.001
|
Ketone bodies, μmol/l
| | | |
Baseline
|
86.8 (10.2)
|
78.1 (12.0)
|
69.4 (10.8)
|
Change from baseline at day 29
|
−12.2 (44.0)
|
139.5 (44.7)
|
408.0 (45.5)
|
Difference vs placebo (95% CI)
| |
151.7 (24.4, 279.0)
|
420.2 (293.3, 547.2)
|
p-value
| |
0.021
|
<0.001
|